NCT05864274View on ClinicalTrials.gov

Improve Cancer-related Cognitive Impairment

NAActive, not recruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

August 1, 2026

Study Completion Date

August 1, 2026

Conditions
Gynecologic CancerChemotherapy EffectChemo-brainCancer-related Cognitive Difficulties
Interventions
DEVICE

Cognitive training application

Patients will participate with a cognitive training application and undergo neurocognitive testing during and after chemotherapy.

Trial Locations (1)

35233

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT05864274 - Improve Cancer-related Cognitive Impairment | Biotech Hunter | Biotech Hunter